JPMorgan lowered the firm’s price target on Gentex (GNTX) to $32 from $34 and keeps a Neutral rating on the shares. The company reported a “surprisingly softer” set of Q4 results while also issuing 2025 guidance materially lower than consensus, the analyst tells investors in a research note. The firm says Gentex’s margin goal was again pushed out.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GNTX:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue